The Korean Journal of Pain

The Korean Pain Society (대한통증학회)
권호 표지

RGS Proteins and Opioid Signaling

Regulator of G-protein Signaling (RGS) 단백질과 아편 신호 전달

  • Kim, Kyung Seon (Department of Rehabilitation, Yonsei University College of Medicine) ;
  • Palmer, Pamela Pierce (Department of Anesthesia and Perioperative Care, University of California) ;
  • Kim, Ki Jun (Department of Anesthesia and Perioperative Care, University of California)
  • Received : 2006.03.15
  • Accepted : 2006.05.08
  • Published : 2006.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

The regulators of the G protein signaling (RGS) proteins are responsible for the rapid acceleration of the GTPase-activity intrinsic to the heterotrimeric G protein alpha subunits. As GTPase-activating proteins (GAP), the RGS proteins negatively regulate the G-protein signals. Recently, the RGS proteins are known to be one of the important regulators of opioid signal transduction and the development of tolerance. The aim of this study was to review the recent discovery and understanding of the role of RGS proteins in opioid signaling and the development of tolerance. This information will be useful for medical personnel, particularly those involved in anesthesia and pain medicine, by helping them improve the effective use of opioids and develop new drugs that can prevent opioid tolerance.

Keywords

References

  1. Beaumont A, Hughes J: Biology of opioid peptides. Annu Rev Pharmacol Toxicol 1979; 19: 245-67 https://doi.org/10.1146/annurev.pa.19.040179.001333
  2. Goldstein A, Naidu A: Multiple opioid receptors: ligand selectivity profiles and binding site signatures. Mol Pharmacol 1989;36: 265-72
  3. Bunzow JR, Saez C, Mortrud M, Bouvier C, Williams JT, Low M, et al: Molecular cloning and tissue distribution of a putative member of the rat opioid recepror gene family that is not a mu, delta or kappa opioid receptor type. FEBS Lett 1994; 347: 284-8 https://doi.org/10.1016/0014-5793(94)00561-3
  4. Kieffet BL, Evans CJ: Opioid toletance-ln search of the holy grail. Cell 2002; 108: 587-90 https://doi.org/10.1016/S0092-8674(02)00666-9
  5. Ikeda K, Kobayashi T, Kumanishi T, Yano R, Sora I, Niki H: Molecular mechanisms of analgesia induced by opioids and ethanol: is the GIRK channel one of the keys? Neurosci Res 2002; 44: 121-31 https://doi.org/10.1016/S0168-0102(02)00094-9
  6. Harrison LM, Kastin AJ, Zadina JE: Opiate tolerance and dependence: receptors, G-ptoteins, and antiopiates. Peptides 1998; 19: 1603-30 https://doi.org/10.1016/S0196-9781(98)00126-0
  7. Borgland SL: Acute opioid receptor desensirization and toletance: is there a link? Clin Exp Pharmacol Physiol 2001; 28: 147-54 https://doi.org/10.1046/j.1440-1681.2001.03418.x
  8. Liu J, Anand KJS: Protein kinases modulate the cellular adaptations associated with opioid toletance and dependence. Brain Res Rev 2001; 38: 1-19 https://doi.org/10.1016/S0165-0173(01)00057-1
  9. Burchett SA: In through the out door: nuclear localization of the regulatots of G protein signaling. J Neurochem 2003; 87: 551-9 https://doi.org/10.1046/j.1471-4159.2003.02047.x
  10. Simon MI, Strathmann MP, Gautam N: Diversity of G proteins in signal ttansduction. Science 1991; 252: 802-8 https://doi.org/10.1126/science.1902986
  11. Popov S, Yu K, Kozasa T, Wilkie TM: The regulatots of G protein signaling (RGS) domains of RGS4, RGS10, and GAIP retain GTPase activating protein activity m vitto. Proc Narl Acad Sci USA 1997; 94: 7216-20
  12. Hollinger S, Hepler JR: Cellular regulation of RGS ptoteins: modulatots and integrators of G protein signaling. Pharmacol Rev 2002; 54: 527-59 https://doi.org/10.1124/pr.54.3.527
  13. De Vties L, Elenko E, Hubler L, Jones TL, Faquhar MG: GAIP is membrane-anchored by palmitoylation and interacts with the activated (GTP-bound) form of G ${\alpha}i$ subunits. Proc Natl Acad Sci USA 1996; 93: 15203-08
  14. Sierra DA, Gilbert DJ, Householder D, Grishm NV, Yu K, Ukidwe P, et al: Evolution of the regulators of G-protein signaling multigene family in mouse and human. Genomics 2002; 79: 177-85 https://doi.org/10.1006/geno.2002.6693
  15. Xie GX, Palmer PP: RGS proteins: new players in the field of opioid signaling and toletance mechanisms. Anesth Analg 2005; 100: 1034-42 https://doi.org/10.1213/01.ANE.0000147711.51122.4B
  16. Heplet JR Betman DM, Gilman AG, Kozasa T: RGS4 and GAIP are GTPase-activating proteins fot Gq ${\alpha}$ and block activation of phospholipase C ${\beta}$ by t-thio-GTP-Gq ${\alpha}$. Proc Narl Acad Sci USA 1997; 94: 428-32
  17. Snow BE, Krumins AM, Brothers GM, Lee SF, Wall MA, Chung S, et al: A G protein gamma subunit-like domain shared berween RGS 11 and othet RGS proteins specifies binding to Gbeta5 subunits. Proc Natl Acad Sci USA 1998; 95: 13307-12
  18. Kikuchi A: Modulation of Wnt signaling by Axin and Axil. Cytokine Growth Factor Rev 1999; 10: 255-65 https://doi.org/10.1016/S1359-6101(99)00017-9
  19. Zhong H, Neubig RR: Regularor of G protein signaling proteins: novel multifunctional drug tatgets. J Phatmacol Exp Ther 2001; 297: 837-45
  20. Ross EM, Wilkie TM: GTPase-activating proteins for hetetotri-meric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins. Annu Rev Biochem 2000; 69: 795-827 https://doi.org/10.1146/annurev.biochem.69.1.795
  21. Elenko E, Fischer T, Niesman I, Harding T, McQuistan T, Von Zasttow M, et al: Spatial regulation of Gi protein signaling in cla-thtin-coated membrane microdomains containing GAIP. Mol Pharmacol 2003; 64: 11-20 https://doi.org/10.1124/mol.64.1.11
  22. Garzon J, Rodriguez-Munoz M, Lopez-Fando A, Garcia-Espana A, Sanchez-Blazquez P: RGSZ1 and GAIP regulate ${\mu}$- but not ${\delta}$-opioid receptors in mouse CNS: role in tachyphylaxis and acute tolerance. Neuropsychopharmacology 2004; 29: 1091-104 https://doi.org/10.1038/sj.npp.1300408
  23. Garzon J, Rodriguez-Munoz M, Lopez-Fando A, Sanchez-Blazquez P: The RGSZ2 protein exists in a complex with ${\mu}$-opioid receptors and regulates the desensitizing capacity of Gz ptoteins. Neuropsychopharmacology 2005; 30: 1632-48 https://doi.org/10.1038/sj.npp.1300726
  24. Sanchez-Blazquez P, Rodriguez-Munoz M, Montero C, Garzon J: RGS-Rz and RGS9-2 proreins control mu-opioid receptor desensirization in CNS: the role of activated G ${\alpha}z$ subunits. Neurophamacology 2005; 48: 134-50 https://doi.org/10.1016/j.neuropharm.2004.08.016
  25. Garzon J, Rodriguez-Mufioz M, Sanchez-Blazquez P: Morphine alters the selective association between mu-opioid teceptors and specific RGS proreins in mouse periaqueductal gtay matter. Neurophamacology 2005; 48: 853-68 https://doi.org/10.1016/j.neuropharm.2005.01.004
  26. Potenza MN, Gold SJ, Roby-Shemkowitz A, Lernet MR, Nestlet EJ: Effects of regulatots of G protein-signaling ptoteins on the functional response of the ${\mu}$-opioid teceptor in a melanophore-based assay. J Pharmacol Exp Ther 1999; 291: 482-91
  27. Gamier M, Zaratin PF, Ficalora G, Valente M, Fontanella L, Rliee MH, et al: Up-regulation of regulator of G protein signaling 4 exptession in a model of neuropathic pain and insensi-tivity to morphine. J Pharmacol Exp Ther 2003; 304: 1299-306 https://doi.org/10.1124/jpet.102.043471
  28. Ippolito DL, Temkin PA, Rogalski SL, Chavkin C: N-terminal tyrosine tesidues within the potassium channel Kir3 modulate GTPase activity of Gi. J Biol Chem 2002; 277: 32692-6 https://doi.org/10.1074/jbc.M204407200
  29. Ulens C, Daenens P, Tytgat J: Changes in GIRK1/GIRK2 deactivation kinetics and basal activity in the presence and absence of RGS4. Life Sci 2000; 67: 2305-17 https://doi.org/10.1016/S0024-3205(00)00820-1
  30. Nakagawa T, Minami M, Satoh M: Up-regulation of RGS4 mRNA by opioid receptor agonists in PC 12 cells expressing cloned ${\mu}$- or K-opioid receptors. Eur J Pharmacol 2001; 433: 29-36 https://doi.org/10.1016/S0014-2999(01)01485-6
  31. Bishop GB, Cullman WE, Curran E, Gutstein HB: Abused drugs modulate RGS4 mRNA levels in tat brain: comparison between acute dtug treatment and a dtug challenge aftet chronic treatment. Neurobiol Dis 2002; 10: 334-43 https://doi.org/10.1006/nbdi.2002.0518
  32. Narita M, Mizuo K, Shibasaki M, Natita M, Suzuki T: Up-regulation of the Gq/$11{\alpha}$ protein and protein kinase C duting the development of sensitization to morphine-induced hyperloco-motion. Neuroscience 2002; 111: 127-32 https://doi.org/10.1016/S0306-4522(01)00515-2
  33. Gold SJ, Han MH, Hetman AE, Ni YG, Pudiak CM, Aghaja-nian GK, et al: Regulation of RGS ptoteins by chronic morphine in rat locus coeruleus. Eur J Neurosci 2003; 17: 971-80 https://doi.org/10.1046/j.1460-9568.2003.02529.x
  34. Garzon J, Rodriguez-Diaz M, Lopez-Fando A, Sanchez-Blazquez P: RGS9 proteins facilitate acute toletance to mu-opioid effects. Eut J Neurosci 2001; 13: 801-11 https://doi.org/10.1046/j.0953-816x.2000.01444.x
  35. Saitoh O, Masuho I, Tetakawa I, Nomoto S, Asano T, Kubo Y: Regulator of G protein signaling 8 (RGS8) tequites its NH2 terminus for subcellular localization and acute desensirization of G protein-gated $K^{+}$ channels. J Biol Chem 2001; 276: 5052-8. https://doi.org/10.1074/jbc.M006917200
  36. Gold SJ, Ni YG, Dohlman HG, Nesrler EJ: Regulatots of G-protem signaling (RGS) proteins: region-specific expression of nine subrypes in rat brain. J Neurosci 1997; 17: 8024-37 https://doi.org/10.1523/JNEUROSCI.17-20-08024.1997
  37. Thomas EA, Danielson PE, Sutcliffe JG: RGS9: A regulator of G-protein signaling with specific exptession in tat and mouse striatum. J Neurosci Res 1998; 52: 118-24 https://doi.org/10.1002/(SICI)1097-4547(19980401)52:1<118::AID-JNR11>3.0.CO;2-6
  38. Zhang JH, Barr VA, Mo Y, Rojkova AM, Liu S, Simonds WF: Nuclear localization of G protein ${\beta}5$ and regulator of G protein signaling 7 in neurons and brain. J Biol Chem 2001; 276: 10284-9 https://doi.org/10.1074/jbc.M009247200
  39. Krumins AM, Barker SA, Huang C, Sunahara RK, Yu K, Wilkie TM, et al: Differentially regulated expression of endogenous RGS4 and RGS7. J Biol Chem 2004; 279: 2593-9 https://doi.org/10.1074/jbc.M311600200
  40. Sanchez-Blazquez P, Rodriguez-Diaz M, Lopez-Fando A, Rodriguez-Muiioz M, Garzon J: The GBeta5 subunit that associates with the R7 subfamily of RGS proteins regulates mu-opioid effecrs. Neuropharmacology 2003; 45: 82-95 https://doi.org/10.1016/S0028-3908(03)00149-7
  41. Kim KJ, Moriyama K, Han KR, Sharma M, Han X, Xie GX, et al: Differential expression of the regulator of G protein signaling RGS9 protein in nociceptive pathways of different age tats. Dev Brain Res 2005; 160: 28-39 https://doi.org/10.1016/j.devbrainres.2005.08.003
  42. Zachariou V, Georgescu D, Sanchez N, Rahman Z, DiLeone R, Berton O, et al: Essential role for RGS9 in opiate action. Proc Natl Acad Sci USA 2003; 100: 13656-61
  43. Garzon J, Lopez-Fando A, Sanchez-Blazquez P: Activation of mu-opioid receptots ttansfers control of G ${\alpha}$ subunits to the regu-lator of G-protein signaling RGS9-2. Role in receptor desensitiza-tion. J Biol Chem 2005; 280: 8951-60 https://doi.org/10.1074/jbc.M407005200
  44. Xu H, Wang X, Wang J, Rothman RB: Opioid peptide receptor studies. 17. attenuation of chtonic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 ptotein in cells expressing the cloned mu opioid teceptot. Synapse 2004; 52: 209-17 https://doi.org/10.1002/syn.20019
  45. Garzon J, Lopez-Fando A, Sanchez-Blazquez P: The R7 subfamily of RGS proteins assists tachyphylaxis and acute tolerance at mu-opioid receptors, Neuropsychopharmacology 2003; 28: 1983-90 https://doi.org/10.1038/sj.npp.1300263
  46. Lopez-Fando A, Rodriguez-Munoz M, Sanchez-Blazquez P, Garzon J: Expression of neural RGS-R7 and G/${\beta}5$ proteins in response to acute and chronic morphine. Neuropsychopharmacology 2005; 48: 134-50
  47. Garzon J, Rodriguez-Munoz M, Torre-Madrid E, Sanchez-Blazquez P: Effector antagonism by the regulators of G protein signaling (RGS) proteins causes desensitization of mu-opioid receptors in the CNS. Psychophatmacology 2005; 180: 1-11
  48. Chasse SA, Dohlman HG: RGS proteins: G protein-coupled receptors meet their match. Assay Drug Dev Technol 2003; 1: 357-64 https://doi.org/10.1089/154065803764958649
  49. Neubig RR, Siderovski DP: Regulatots of G-protein signalling as new central nervous system drug tatgets. Nat Rev Drug Discov 2002; 1: 187-97 https://doi.org/10.1038/nrd747